REGN Balance Sheet
Regeneron Pharmaceuticals Inc - Assets, Liabilities & Stockholders' Equity
Total Assets
$37.76B
Total Liabilities
$8.41B
Shareholders' Equity
$29.35B
Cash Position
$2.49B
Assets
As of: FY
Current Assets
Cash & Equivalents
$2.49B
Total Current Assets
$18.66B
Non-Current Assets
Total Assets
$37.76B
Liabilities & Equity
Current Liabilities
Total Current Liabilities
$3.94B
Non-Current Liabilities
Total Liabilities
$8.41B
Stockholders' Equity
Retained Earnings
$31.67B
Total Equity
$29.35B
Total Liabilities & Equity
$37.76B
Should equal Total Assets
Key Balance Sheet Ratios
Current Ratio
4.73
Current Assets / Current Liabilities
Working Capital
$14.72B
Current Assets - Current Liabilities
Balance Sheet Health
Liquidity: Strong
Current ratio of 4.73 indicates the company has ample short-term assets to cover short-term liabilities.
Cash Position: 6.6% of Assets
$2.49B in cash provides adequate financial flexibility.
View Complete Financial Analysis
Explore detailed financials, income statements, cash flows, and more
Open Full FinancialsFrequently Asked Questions
What are REGN's total assets?
REGN has total assets of $37.76B, down from $37.76B in the previous period.
How much debt does REGN have?
Debt information for REGN can be found in the balance sheet.
What is REGN's cash position?
REGN has $2.49B in cash and cash equivalents, representing 6.6% of total assets.
What is REGN's stockholders' equity?
REGN's stockholders' equity is $29.35B. This represents the book value of the company and shareholder ownership stake.
What is REGN's current ratio?
REGN has a current ratio of 4.73. This means the company has $4.73 in current assets for every $1 in current liabilities. A ratio above 1.0 indicates good short-term financial health.
How healthy is REGN's balance sheet?
REGN's balance sheet shows $37.76B in total assets, $8.41B in liabilities, and $29.35B in equity. The current ratio of 4.73 suggests strong liquidity.